Magnesium Oral Supplementation for Acute Non-specific Low Back Pain

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

June 10, 2018

Primary Completion Date

March 15, 2019

Study Completion Date

March 8, 2020

Conditions
Low Back PainAcute Pain
Interventions
DRUG

Magnesium

Patients were treated with etodolac 400mg twice a day plus magnesium oral supplementation once a day for acute low back pain and clinical evaluation of participants was performed at first admission to emergency department, at 4th and 10th days after the initiation of designated treatment

DRUG

NSAID

Patients were treated with etodolac 400mg twice a day for acute low back pain and and clinical evaluation of participants was performed at first admission to emergency department, at 4th and 10th days after the initiation of designated treatment

DRUG

paracetamol

Patients were treated with etodolac 400mg twice a day plus 500mg paracetamol twice a day paracetamol for acute low back pain and and clinical evaluation of participants was performed at first admission to emergency department, at 4th and 10th days after the initiation of designated treatment

Trial Locations (1)

34093

Istanbul University Istanbul Faculty of Medicine, Istanbul

All Listed Sponsors
lead

Istanbul University

OTHER

NCT04626063 - Magnesium Oral Supplementation for Acute Non-specific Low Back Pain | Biotech Hunter | Biotech Hunter